Annual Cash & Cash Equivalents
$68.42 M
+$12.51 M+22.38%
December 31, 2022
Summary
- As of February 10, 2025, ORTX annual cash & cash equivalents is $68.42 million, with the most recent change of +$12.51 million (+22.38%) on December 31, 2022.
- During the last 3 years, ORTX annual cash & cash equivalents has risen by +$49.37 million (+259.12%).
Performance
ORTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$23.47 M
-$14.80 M-38.68%
September 30, 2023
Summary
- As of February 10, 2025, ORTX quarterly cash and cash equivalents is $23.47 million, with the most recent change of -$14.80 million (-38.68%) on September 30, 2023.
- Over the past year, ORTX quarterly cash and cash equivalents has dropped by -$57.28 million (-70.94%).
Performance
ORTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ORTX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +22.4% | -70.9% |
| 3 y3 years | +259.1% | -43.0% |
| 5 y5 years | -23.9% | - |
ORTX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -18.3% | -70.9% | at low |
| 5 y | 5-year | at high | -72.2% | -76.5% | -18.8% |
| alltime | all time | -79.6% | -94.9% | -93.0% | -18.8% |
Orchard Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $23.47 M(-38.7%) |
| Jun 2023 | - | $38.27 M(-37.8%) |
| Mar 2023 | - | $61.49 M(-10.1%) |
| Dec 2022 | $68.42 M(+22.4%) | $68.42 M(-15.3%) |
| Sep 2022 | - | $80.75 M(+51.0%) |
| Jun 2022 | - | $53.47 M(-12.0%) |
| Mar 2022 | - | $60.77 M(+8.7%) |
| Dec 2021 | $55.91 M(+1.4%) | $55.91 M(-24.8%) |
| Sep 2021 | - | $74.32 M(-25.6%) |
| Jun 2021 | - | $99.93 M(+26.7%) |
| Mar 2021 | - | $78.88 M(+43.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $55.13 M(+189.4%) | $55.13 M(+33.9%) |
| Sep 2020 | - | $41.16 M(-0.0%) |
| Jun 2020 | - | $41.17 M(+51.9%) |
| Mar 2020 | - | $27.10 M(+42.2%) |
| Dec 2019 | $19.05 M(-94.3%) | $19.05 M(-46.3%) |
| Sep 2019 | - | $35.48 M(-73.3%) |
| Jun 2019 | - | $132.78 M(-55.1%) |
| Mar 2019 | - | $295.41 M(-12.0%) |
| Dec 2018 | $335.84 M(+273.8%) | $335.84 M(+588.7%) |
| Jun 2018 | - | $48.76 M(-45.7%) |
| Dec 2017 | $89.86 M(+2469.5%) | $89.86 M |
| Dec 2016 | $3.50 M | - |
FAQ
- What is Orchard Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Orchard Therapeutics?
- What is Orchard Therapeutics annual cash & cash equivalents year-on-year change?
- What is Orchard Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Orchard Therapeutics?
- What is Orchard Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Orchard Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of ORTX is $68.42 M
What is the all time high annual cash & cash equivalents for Orchard Therapeutics?
Orchard Therapeutics all-time high annual cash & cash equivalents is $335.84 M
What is Orchard Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, ORTX annual cash & cash equivalents has changed by +$12.51 M (+22.38%)
What is Orchard Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ORTX is $23.47 M
What is the all time high quarterly cash and cash equivalents for Orchard Therapeutics?
Orchard Therapeutics all-time high quarterly cash and cash equivalents is $335.84 M
What is Orchard Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, ORTX quarterly cash and cash equivalents has changed by -$57.28 M (-70.94%)